ACAMPROSATE CALCIUM
Generic: ACAMPROSATE CALCIUM
Somerset TherapeuticsManufacturer
ORALRoute
ACAMPROSATE CALCIUMActive Substance
2026-03-16Original Approval
ACAMPROSATE CALCIUM is FDA application ANDA218984, sponsored by SOMERSET THERAPS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
OFF LABEL USE
20 reports
2
VOMITING
20 reports
3
ACUTE KIDNEY INJURY
15 reports
4
HYPOTENSION
14 reports
5
ASTHENIA
13 reports
6
CONDITION AGGRAVATED
13 reports
7
COMA
11 reports
8
FATIGUE
11 reports
9
HEADACHE
11 reports
10
HEPATIC ENCEPHALOPATHY
11 reports